In Brief: House Budget Committee
Executive Summary
House Budget Committee: March 16 "illustrative" list of discretionary spending cuts under the House $100 bil., five-year tax cut funding bill would eliminate HHS' Agency for Health Care Policy & Research by zeroing out support, saving an estimated $578 mil. over a five-year period. The plan would cut $2.5 bil. from the budget of the National Institutes of Health to encourage "enhanced prioritization" of NIH-supported research and reduce funding by 5%. Other targeted programs include a reduction in General Accounting Office funding by 15%, or $328 mil...
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth